Fund holdings · portfolios to September 2026
Mutual funds holding GlaxoSmithKline Pharmaceuticals
122 mutual funds held GlaxoSmithKline Pharmaceuticals (GLAXO) in their portfolios to September 2026: 61 active funds and 61 index funds and ETFs.
What active funds did in September
4 increased, 2 opened a new position, 5 reduced and 1 exited.
6 increased6 reduced
The 10 largest holders, by weight in the fund
| Fund | Weight | In September |
|---|---|---|
| quant Healthcare Fund | 9.69% | Unchanged |
| Bandhan Healthcare Fund | 3.39% | Unchanged |
| Baroda BNP Paribas Dividend Yield Fund | 3.28% | Unchanged |
| Quant Mid Cap Fund | 3.22% | Increased |
| Nippon India Pharma Fund | 3.11% | Unchanged |
| quant Dynamic Asset Allocation Fund | 2.82% | Unchanged |
| Bajaj Finserv Multi Cap Fund | 2.65% | Increased |
| Bajaj Finserv Balanced Advantage Fund | 2.64% | Unchanged |
| DSP Nifty Midcap 150 Quality 50 ETFETF | 2.55% | Unchanged |
| UTI Nifty Midcap 150 Quality 50 Index FundIndex fund | 2.55% | Unchanged |
All 122 funds that hold GLAXO, and its active holders month by month
Loading…
Funds publish their portfolios once a month, within about ten days of the month end. A count of funds, not a call on the stock: read it beside the stage and the trend on GlaxoSmithKline Pharmaceuticals’s page.